Skip to main content
SpringerLink
Log in

Untersuchungen über Physiologie und Pathophysiologie des sympathikoadrenalen Systems durch Bestimmung der Vanillin-Mandelsäure-Ausscheidung im Harn mit dünnschichtehromatographischer Technik

  • Published:
Archiv für Kreislaufforschung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Schrifttum

  1. Alexander, M. K., D. F. Barrowcliff, A. P. Prior, R. Robinson, andP. Smith, Secretory properties of phaeochromocytomas. LancetI, 951 (1962).

    Google Scholar 

  2. Armstrong, M. D. andA. McMillan, Studies on the formation of 3-methoxy-4-hydroxy-d-mandelic acid, a urinary metabolite of norepinephrine and epinephrine. In: Symposium on Catecholamines. S. 301 (Bethesda 1958).

  3. Armstrong, M. D., A. McMillan, andK. N. F. Shaw, 3-Methoxy-4-hydroxy-d-mandelic acid, a urinary metabolite of norephinephrine. Biochim. biophys. Acta25, 422 (1957).

    PubMed  Google Scholar 

  4. Armstrong, M. D., K. N. F. Shaw, andA. McMillan, The phenolic acids in human urine. Paper chromatography of phenolic acids. J. biol. Chem.218, 293 (1956).

    PubMed  Google Scholar 

  5. Axelrod, J., O-Methylation of epinephrine and other catechols in vitro and in vivo. Science126, 400 (1957).

    PubMed  Google Scholar 

  6. Axelrod, J., Presence, formation and metabolism of normetanephrine in the brain. Science127, 754 (1958).

    PubMed  Google Scholar 

  7. Axelrod, J., Metabolism of epinephrine and other sympathomimetic amines. Physiol. Rev.39, 751 (1959).

    PubMed  Google Scholar 

  8. Axelrod, J., Enzymatic conversion of metanephrine to normetanephrine. Experientia16, 502 (1960).

    PubMed  Google Scholar 

  9. Axelrod, J., Metabolism of adrenaline and noradrenaline. In: Symposium on the clinical chemistry of monoamines, Manchester 1962. (Amsterdam 1963).

  10. Axelrod, J., G. Hertting, andR. W. Patrick, Inhibition of H8-norepinephrine release by monoamine oxidase inhibitors. J. Pharmacol. exper. therap.134, 325 (1961).

    Google Scholar 

  11. Axelrod, J., J. K. Inscoe, S. Senoh, andB. Witkop, O-Methylation, the principal pathway for the metabolism of epinephrine and norepinephrine in the rat. Biochim. biophys. Acta27, 210 (1958).

    PubMed  Google Scholar 

  12. Axelrod, J., I. J. Kopin, andJ. D. Mann, 3-Methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine. Biochim. biophys. Acta36, 576 (1959).

    PubMed  Google Scholar 

  13. Axeilrod, J. andR. Tomchick, O-Methyl transferase. Fed. Proc.17, No. 1361 (1958).

    Google Scholar 

  14. Axelrod, J. andR. Tomchick, Increased rate of metabolism of epinephrine and norepinephrine by sympathomimetic amines. J. Phrarmacol. exper. Therap.130, 367 (1960).

    Google Scholar 

  15. Axelrod, J., H. Well-Malherbe, andR. Tomchick, The physiological disposal of H3-epinephrine and its metabolite metanephrine. J. Pharmacol. exper. Therap.127, 251 (1959).

    Google Scholar 

  16. Axelrod, J., L. G. Whitby, G. Hertting, andI. J. Kopin, Studies on the metabolism of catecholamines. Circ. Res.9, 715 (1961).

    PubMed  Google Scholar 

  17. Barger, G. andH. H. Dale, Chemical structure and sympathomimetic amines. J. Physiol., London41, 19 (1910/11).

    Google Scholar 

  18. Bass, N. M. andV. V. Glaviano, Blood pressure, heart rate and adrenal catecholamines prior to ventricular fibrillation. Amer. J. Physiol.201, 109 (1961).

    PubMed  Google Scholar 

  19. Berdal, P., M. Braaten, C. Cappelen jr.,E. A. Mylius, andO. Walaas, Noradrenaline-adrenaline producing nonchromaffin paraganglioma. Acta med. Scand.172, 249 (1962).

    PubMed  Google Scholar 

  20. Bernheimer, H., H. Ehringer, P. Heistracher undO. Kraupp, Untersuchungen über den Abbau von l(−)- und d(+)-Adrenalin im Rattenorganismus. Biochem. Z.332, 416 (1960).

    PubMed  Google Scholar 

  21. Bertler, Å., N.-Å. Hillarp, andE. Rosengren, Storage of new-formed catecholamines in the adrenal medulla. Experientia16, 419 (1960).

    Google Scholar 

  22. Bettex, M. andH. Käser, Diagnostic and prognostic value of the determination of urinary output of vanillyl-mandelic acid in tumours of sympathetic nervous system. Arch. Dis. Childhood37, 138 (1962).

    Google Scholar 

  23. Bettge, S., Untersuchung über den Nachweis der sympathikomimetischen Hormone in blut und Urin des Menschen. Z. Kreislaufforschg.49, 534 (1960).

    Google Scholar 

  24. —, Untersuchungen über die Urinausscheidung der sympathiko-mimetischen Hormone bei Hypertonikern. Z. Kreislaufforschg.49, 543 (1960).

    Google Scholar 

  25. Birke, G., H. Dunér, U. S. vonEuler, andL. O. Plantin, Studies on the adrenocortical, adrenomedullary and adrenergic nerve activity in essential hypertension. Z. Vit.-Horm.-Fermentforschg.9, 41 (1957).

    Google Scholar 

  26. Birke, G., H. Dunér, S. O. Liljedahl, B. Pernow, andL. O. Plantin, Histamine, catecholamines and adremocortical steroids in burns. Acta chir. Scand.114, 87 (1958).

    PubMed  Google Scholar 

  27. Blaschko, H., Amine oxidase and anime metabolism. Pharmacol. Rev.4, 415 (1952).

    PubMed  Google Scholar 

  28. —, Metabolism of epinephrine and norepinephrine. Pharmacol. Rev.6, 23 (1954).

    PubMed  Google Scholar 

  29. Blaschko, H., P. Hagen, andA. D. Weich, Observations on the intracellular granules of the adrenal medulla. J. Physiol., London129, 27 (1955).

    Google Scholar 

  30. Blaschko, H., D. Richter, andSchlossmann, The inactivation of adrenaline. J. Physiol. London90, 1 (1937).

    Google Scholar 

  31. Blaschko, H andA. D. Welch, Localization of adrenaline in cytoplasmic particles of the bovine adrenal medulla. Arch. exper. Path. Pharmakol.219, 17 (1953).

    Google Scholar 

  32. Blumberg, A. G. andH. Goldenberg, Relation of the mecholyl test to catecholamine excretion. Proc. Soc. exper. Biol., N. Y.106, 867 (1961).

    Google Scholar 

  33. Bollman, J. L., E. V. Flcok, G. M. Roth, andW. F. Kvale, Catecholamines in patients with pheochromocytoma. J. Lab. Clin. Med.56, 506 (1960).

    Google Scholar 

  34. Brauns, H. u.H. J. Kuschke, Die Katecholaminausscheidung der Ratte nach Röntgenbestrahlung. Fortschr. Röntgenstr.94, 827 (1961).

    Google Scholar 

  35. Bridgers, J. F. andS. Kaufman, The enzymatic conversion of epinine to epinephrine. J. biol. Chem.237, 526 (1962).

    PubMed  Google Scholar 

  36. Bülbring, E., The metylaton of noradrenaline by minced suparental tissues. Brit. J. Pharmacol.4, 234 (1949).

    Google Scholar 

  37. Burger, M., K. Giger, J. Kägi u.Langemann, Änderung der Adrenalin- und Noradrenalin-Konzentration im menschlichen Blutplasma unter Phentolamin (Regitin). Helv. physiol. Pharmacol. Acta15, 8 (1957).

    PubMed  Google Scholar 

  38. Cannon, W. B., The emergency function of the adrenal medulla in pain and the major emotions. Amer. J. Physiol.33, 356 (1914).

    Google Scholar 

  39. Cannon, W. B., Bodily changes in pain, hunger, fear, and rage. Ch. T. Branford Co., Boston 1915 (2nd ed. 1953).

    Google Scholar 

  40. Cannon, W. B., The isolated heart as an indicator of adrenal secretion induced by pain, asphyxis, and excitement. Amer. J. Physiol.50, 399 (1919).

    Google Scholar 

  41. Cannon, W. B., J. C. Aub, andC. A. L. Binger, A note on the effect of nicotine injection on adrenal secretion. J. Pharmacol. exper. Therap.3, 379 (1912).

    Google Scholar 

  42. Cannon, W. B. andR. G. Hoskins, The effect of asphyxia, hyperpnoea, and sensory stimulation on adrenal secretion. Amer. J. Physiol.29, 274 (1911).

    Google Scholar 

  43. Cannon, W. B. andD. De La Paz, Emotional stimulation of adrenal secretion. Amer. J. Physiol.28, 64 (1911).

    Google Scholar 

  44. Cannon, W. B., A. Rosenblueth, Studies on conditions of activity in endocrine organs. XXIV. Sympathin E and Sympathin I. Amer. Physiol.104, 557 (1934).

    Google Scholar 

  45. Cannon, W. B., A. T. Shohl, andW. S. Wright, Emotional glycosuria. Amer. J. Physiol.29, 280 (1911).

    Google Scholar 

  46. Carlsson, A. andN.-Å. Hillarp, Release of adenosine triphosphate along with adrenaline and noradrenaline following stimulation of the adrenal medulla. Acta physiol. scand.37, 235 (1956).

    PubMed  Google Scholar 

  47. Carlsson, A. andN.-Å. Hillarp, On the state of catecholamines of the adrenal medullary granules. Acta physiol. scand.44, 163 (1958).

    PubMed  Google Scholar 

  48. Chapman, R. C., V. E. Kemp, andI. Tallaferro, Pheochromocytoma associated with multiple neurofibromatosis and intracranial hemangioma. Amer. J. Med.26, 883 (1959).

    PubMed  Google Scholar 

  49. Chidsey, C. A., D. C. Harrison, andE. Braunwald, Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. New Engl. J. Med.267, 650 (1962).

    Google Scholar 

  50. Clark, W. G. andR. S. Pogrund, Inhibition of DOPA decarboxylase in vitro and in vivo. Circulation Res.9, 721 (1961).

    PubMed  Google Scholar 

  51. Coleman, B. andV. V. Laviano, Tissue levels of norepinerphrine and epinephrine in hemorrhagic shock. Science139, 54 (1963).

    PubMed  Google Scholar 

  52. Cooper, T. andA. Sjoerdsma, Depletion of splenie norepinephrine in rat by celiac ganglionectomy. Proc. Soc. exper. Biol., N. Y.109, 538 (1962).

    Google Scholar 

  53. Coward, R. F., P. Smith, O. S. Wilson, andR. Robinson, Urinary amines after adrenalectomy. Nature, London193, 1295 (1962).

    Google Scholar 

  54. Crout, J. R., Inhibition of catechol-o-metyl transferase by pyrogallol in the rat. Biochem. Pharmacol.6, 47 (1961).

    PubMed  Google Scholar 

  55. Crout, J. R., J. J. Pisano, andA. Sjoerdsma, Urinary excretion of catecholamines and their metabolites in pheochromocytoma. Amer. Heart J.61, 375 (1961).

    PubMed  Google Scholar 

  56. Crout, J. R. andA. Sjoerdsma, The clinical and laboratory significance of serotonin and catechol amines in bananas. New Engl. J. Med.261, 23 (1959).

    PubMed  Google Scholar 

  57. Crout, J. R. andA. Sjoerdsma, Catechol amines in the localization of pheochromocytoma. Circulation22, 516 (1960).

    PubMed  Google Scholar 

  58. Daly, J. W., J. Axelrod, andB. Witkop, Dynamic aspects of enzymatic o-methylation and-demethylation of catechols in vitro and in vivo. J. biol. Chem.235, 1155 (1960).

    PubMed  Google Scholar 

  59. De Eds, F., A. N. Booth, andF. T. Jones, Methylation and dehydroxylation of phenolic compounds by rats and rabbits. J. biol. Chem.225, 615 (1957).

    PubMed  Google Scholar 

  60. Dengler, H. J., Die Wirkung des Thyroxin auf die Aufnahme und den Stoffwechsel der Katecholamine des Herzens. Verh. dtsch. Ges. Kreislaufforschg.27, 252 (1961).

    Google Scholar 

  61. Dengler, H., H. Klemm undG. Reichel, Die Katecholaminausscheidung bei Infektionskrankheiten. Klin. Wschr.37, 798 (1959).

    PubMed  Google Scholar 

  62. Dengler, H. undG. Reichel, Hemmung der Dopadekarboxylase durch Alpha-Methyl-dopa in vivo. Arch. exp. Path. Pharmakol.234, 275 (1958).

    Google Scholar 

  63. Dennis, D. J., H. Blaschko, andA. D. Welch, The conversion of dihydroxy-phenylalanine-C14 (Dopa) to norepinephrine by bovine adrenal medullary homogenates. J. Pharmacol. exper. Therap.117, 208 (1956).

    Google Scholar 

  64. Dirscherl, W., H. Thomas undH. Schrieffers, Vanillinsäure als Endprodukt des Abbaues von Adrenalin und Noradrenalin. Acta endocrin.39, 385 (1962).

    Google Scholar 

  65. Eichholtz, F., Über den Einfluß von Nikotin und nikotinartig wirkenden Substanzen auf die Adrenalinsekretion Arch. exper. Path. Pharmakol.99, 172 (1923).

    Google Scholar 

  66. Eichholtz, F. undE. Roesch, Pharmakologische Reaktionen an den Synapsen des Nebennierenmarks. Arch. internat. pharmacodyn.78, 521 (1949)

    Google Scholar 

  67. Elliott, T. R., On the action of adrenaline. J. Physiol., London31, XX (1904).

    Google Scholar 

  68. Elmadjian, F., Excretion and metabolism of epinephrine. In: Symposium on Catecholamines, S. 301 (Bethesda 1958).

  69. Elmadjian, F., J. M. Hope, andE. T. Lamson, Excretion of epinephrine and norepinephrine in various emotional states. J. clin. Endocr.17, 608 (1957).

    PubMed  Google Scholar 

  70. Elmadjian, F., E. T. Lamson, andR. Neri, The nature of adrenaline and noradrenaline in normal human urine. J. clin. Endocr.16, 216 (1956).

    PubMed  Google Scholar 

  71. Emlet, J. R., K. S. Grimson, D. M. Bell, andE. S. Orgain, Use of piperoxan and regitine as routine tests in patients with hypertonsion. J. Amer. Med. Ass.146, 1383 (1951).

    Google Scholar 

  72. Engel, A. andU. S. von Euler, Diagnostic value of increased urinary output of noradrenaline and adrenaline in phaeochromocytoma. LancetI, 387 (1950).

    Google Scholar 

  73. Eränkö, O. andM. Härkönen, Distribution and concentration of adrenaline and noradrenaline in the adrenal medulla of the rat following depletion induced by muscular work. Acta physiol. Scand.51, 247 (1961).

    PubMed  Google Scholar 

  74. Erspamer, V., Identification of octopamine as l,p-hydroxyphenylaethanolamine. Nature London169, 375 (1952).

    Google Scholar 

  75. von Euler, U. S., A specific sympathicomimetic ergone in adrenergic nerve fibers (sympathin) and its relation to adrenalin and nor-adrenalin. Acta physiol. Scand.12, 73 (1946).

    Google Scholar 

  76. von Euler, U. S., Identification of the sympathicomimetic ergone in adrenergic nerve fibers (sympathin N) with laevo-noradrenaline. Acta physiol. Scand.16, 63 (1948).

    Google Scholar 

  77. von Euler, U. S., Adrenaline and noradrenaline. Distribution and action. Pharmacol. Rev.6, 15 (1954).

    PubMed  Google Scholar 

  78. von Euler, U. S., Ausscheidungsmuster von Catecholaminen während verschiedener physiologischer und pathophysiologischer Zustände. Vortrag, Symposium über Funktionsabläufe unter emotionellen Belastungen, (Wien 1963).

  79. von Euler, U. S. andI. Floding, Fluorimetric estimation of noradrenaline (NA) and adrenaline (A) in urine. Acta physiol. Scand.33, Suppl.118, 57 (1955).

    PubMed  Google Scholar 

  80. von Euler, U. S. andI. Floding, Methylation of noradrenaline in beef suprarenal homogenates. Acta physiol. Scand.42, 251 (1958).

    PubMed  Google Scholar 

  81. von Euler, U. S. andC. Frankson, Increase in noradrenaline excretion following activation of the vasomotor system during tilting in adrenalectomized patients. Acta physiol. Scand.38, 275 (1957).

    PubMed  Google Scholar 

  82. von Euler, U. S. andS. Hellner, Noradrenaline excretion in muscular work. Acta physiol. Scand.26, 183 (1952).

    PubMed  Google Scholar 

  83. von Euler, U. S., S. Hellner, andA. Purkhold, Excretion of noradrenaline in urine in hypertension. Scand. J. Clin. Lab. Invest.6, 54 (1954).

    PubMed  Google Scholar 

  84. von Euler, U. S., S. Hellner-Björkman, andI. Orwén, Diurnal variations in the excretion of free and conjugated noradrenaline and adrenaline in urine from healthy subjects. Acta physiol. Scand.33, Suppl.118, 10 (1955).

    PubMed  Google Scholar 

  85. von Euler, U. S., D. Ikkos, andR. Luft, Adrenaline excretion during resting conditions and after insulin in adrenalectomized human subjects. Acta endocrinol.38, 441 (1961).

    PubMed  Google Scholar 

  86. von Euler, U. S. andF. Lishajko, Catechol amines in the vascular wall. Acta physiol. Scand.42, 333 (1958).

    PubMed  Google Scholar 

  87. von Euler, U. S. andF. Lishajko, The estimation of catechol amines in urine. Acta physiol. Scand.45, 122 (1959).

    PubMed  Google Scholar 

  88. von Euler, U. S. andF. Lishajko, Effect of reserpine on release of noradrenaline from transmitter granules in adrenergic nerves. Science132, 351 (1960).

    Google Scholar 

  89. von Euler, U. S. andR. Luft, Noradrenaline output in urine after infusion in man. Brit. J. Pharmacol.6, 286 (1951).

    PubMed  Google Scholar 

  90. von Euler, U. S. andR. Luft, Effect of insulin on urinary excretion of adrenaline and noradrenaline. Metabolism1, 528 (1952).

    PubMed  Google Scholar 

  91. von Euler, U. S. andI. Orwén, Preparation of extracts of urine and organs for estimation of free and conjugated noradrenaline and adrenaline. Acta physiol. Scand.33, Suppl.118, 1 (1955).

    Google Scholar 

  92. von Euler, U. S. andG. Ström, Present status of diagnosis and treatment of pheochromocytoma. Circulation15, 5 (1957).

    PubMed  Google Scholar 

  93. von Euler, U. S. andB. Zetterström, The rôle of amine oxidase in the inactivation of catechol amines injected in man. Acta physiol. Scand.33, suppl.118, 26 (1955).

    PubMed  Google Scholar 

  94. Ewer, R. W., J. A. Arkins, B. T. Hefferman, andE. J. Lemmon, Increased urinary excretion of catechol amines in the absence of known chromaffin tumors. A survey by the rabbit aortic-strip method of 802 unselected, hospitalized patients. J. clin. Endocr.19, 1037 (1959).

    PubMed  Google Scholar 

  95. Faredin, I., S. Benkö, M. Winter,Á. Botos, andG. Hetényi, Pathological changes in the adrenaline and noradrenaline content of arterial vessel wall in the dog. Acta med. Acad. Sci. Hung.17, 247 (1961).

    PubMed  Google Scholar 

  96. Fleetwood, M. F., Determination of adrenergic substance in blood related to anxiety. Identification as noradrenaline. Amer. J. Physiol.166, 314 (1951).

    PubMed  Google Scholar 

  97. Forssman, O., G. Hansson, andC. C. Jensen, The adrenal function in coronary thrombosis. Acta med. scand.142, 441 (1952).

    PubMed  Google Scholar 

  98. Fowler, N. O., R. Shabetai, andJ. C. Holmes, Adrenal medullary secretion during hypoxia, bleeding, and rapid intravenous infusion. Circ. Res.9, 427 (1959).

    Google Scholar 

  99. Frankenhaeuser, M. andS. Kareby, Effect of meprobamate on catecholamine excretion during mental stress. Perceptual & Motor Skills15, 571 (1962).

    Google Scholar 

  100. Frankenhaeuser, M. andB. Post, Catecholamine excretion during mental work as modified by centrally acting drugs. Reports from the Psychol. Labor., Univ. Stockholm,102 (1961).

  101. Fränkel, F., Ein Fall von doppelseitigem, völlig latent verlaufenen Nebennierentumor und gleichzeitiger Nephritis mit Veränderungen am Circulationsapparat und Retinitis. Virch. Arch. path. Anat.103, 244 (1886).

    Google Scholar 

  102. Friedman, M., S. S. George, S. O. Byers, andR. H. Rosenman, Excretion of catecholamines, 17-ketosteroids, 17-hydroxycorticoids and 5-hydroxyindole in men exhibiting a particular behavior pattern (A) associated with high incidence of clinical coronary disease. J. clin. Invest.39, 758 (1960).

    PubMed  Google Scholar 

  103. Funkenstein, D. H., S. H. King, andM. Drolette, Direction of anger during laboratory stress-inducing situation. Psychosomat. Med.16, 404 (1954).

    Google Scholar 

  104. Gazes, P. C., J. A. Richardson, andE. F. Woods, Plasma catechol amine concentrations in myocardial infarction and angina pectoris. Circulation19, 657 (1959).

    PubMed  Google Scholar 

  105. Gibbs, H. D., Phenol tests. III. The indophenol test. J. biol. Chem.72, 649 (1927).

    Google Scholar 

  106. Gifford, R. W., G. M. Roth, andW. F. Kvale, Evaluation of a new adrenolytic drug (regitin) as test for pheochromocytoma. J. Amer. Med. Ass.149, 1628 (1952).

    Google Scholar 

  107. Gitlow, S. F., M. Mendlowitz, S. Khassis, G. Cohen, andJ. Sha, The diagnosis of pheochromocytoma by determination of urinary 3-methoxy, 4-hydroxymandelio acid. J. clin. Invest.39, 221 (1960).

    PubMed  Google Scholar 

  108. Gitlow, S. E., M. Mendlowitz, E. Kruk, andS. Khassis, Diagnosis of pheochromocytoma by assay of catecholamine metabolites. Circ. Res.9, 746 (1961).

    Google Scholar 

  109. Gitlow, S. E., L. Ornstein, M. Mendlowitz, S. Khassis, andE. Kruk, A simple colorimetric urine test for pheochromocytoma. Amer. J. Med.29, 921 (1960).

    Google Scholar 

  110. Glenner, G. G., J. R. Crout, andW. C. Roberts, A functional carotidbody-like tumor. Arch. Pathol.73, 230 (1962).

    PubMed  Google Scholar 

  111. Goldberg, L. I., R. D. Bloodwell, E. Braunwald, andA. G. Morrow, The direct effects of norepinephrine epinephrine, and methoxamine on myocardial contractile force in man. Circulation22, 1125 (1960).

    PubMed  Google Scholar 

  112. Goldenberg, M., C. Snyder, andH. Aranow jr., New test for hypertension due to circulating epinephrine. J. Amer. Med. Ass.135, 961 (1947).

    Google Scholar 

  113. Goldfien, A., S. Zileli, De W. Goodman, andG. W. Thorn, The estimation of epinephrine and norepinephrine in human plasma. J. clin. Endocr.21, 281 (1961).

    PubMed  Google Scholar 

  114. Goldstein, M. andJ. F. Contrera, Studies on inhibition of 3,4-dihydroxyphenylethylamine (dopamine) β-oxidase in vitro. Experientia17, 267 (1961).

    PubMed  Google Scholar 

  115. Goldstein, M. andJ. F. Contrera, The substrate specifity of phenylamine-β-hydroxylase. J. biol. Chem.237 1898 (1962).

    PubMed  Google Scholar 

  116. Goldstein, M. andS. B. Gertner, Formation of a new metabolite of epinephrine and norepinephrine in liver and kidney. Nature, London187, 147 (1960).

    Google Scholar 

  117. Goldstein, M., A. J. Friedhoff, S. Pomerantz, andJ. F. Contrera, The formation of 3,4-dihydroxyphenylethanol and 3-methoxy-4-hydroxyphenylethanol from 3,4-dihydroxyphenylethylamine in the rat. J. biol. Chem.236, 1816 (1961).

    PubMed  Google Scholar 

  118. Goldstein, M., A. J. Friedhoff, C. Simmons, andN. N. Prochoroff, Indirect evidence of synthesis of norepinephrine from 3-hydroxytyramine-C14 in vivo. Proc. Soc. exp. Biol. N. Y.103, 137 (1960).

    Google Scholar 

  119. Gollwitzer-Meier, K., K. Kramer u.E. Krüger, Die Wirkung des Adrenalins auf die Energetik des Herzens. Pflügers Arch. ges. Physiol.237, 639 (1936).

    Google Scholar 

  120. Goodall, McC., Sympathicoadrenal response to gravitational stress. J. clin. Invest.41, 197 (1962).

    PubMed  Google Scholar 

  121. Goodall, McC. andM. L. Berman, Urinary output of adrenaline, noradrenaline, and 3-methoxy-4-hydroxymandelic acid following centrifugation and anticipation of centrifugation. J. clin. Invest.39, 1533 (1960).

    PubMed  Google Scholar 

  122. Goodall, McC. andM. Bogdonoff, Essential hypertension with an elevated noradrenaline excretion. Amer. Heart J.61, 640 (1961).

    PubMed  Google Scholar 

  123. Goodall, McC. andB. W. Haynes jr., Adrenal medullary insufficiency in severe thermal burns J. clin. Invest.39, 1927 (1960).

    PubMed  Google Scholar 

  124. Goodall, McC. andN. Kirshner, Biosynthesis of adrenaline and noradrenaline in vitro. J. biol. Chem.226, 213 (1957).

    PubMed  Google Scholar 

  125. Goodall, McC., N. Kirshner, andL. Rosen, Metabolism of noradrenaline in the human. J. clin. Invest.38, 707 (1959).

    PubMed  Google Scholar 

  126. Goodall, McC. andM. Long, Effect of whole-hody X-irradiation on the adrenal medulla and the hormones adrenaline and noradrenaline. Amer. J. Physiol.197, 1265 (1959).

    PubMed  Google Scholar 

  127. Goodall, McC., C. Stone andB. W. Haynes jr., Urinary output of adrenaline and noradrenaline in severe burns. Ann. Surg.145, 479 (1957).

    PubMed  Google Scholar 

  128. Gray, I., andW. P. Beetham jr., Changes in plasma concentration of epinephrine and norepinephrine with muscular work. Proc. Soc. exper. Biol., N. Y.96, 636 (1957).

    Google Scholar 

  129. Green, D. E. andD. E. Richter, Adrenaline and adrenochrome. Biochem. J.31, 596 (1937).

    Google Scholar 

  130. Greenberg, R. E. andL. I. Gardner, Catecholamine metabolism in a functional neural tumor. J. clin. Invest.39, 1729 (1960).

    PubMed  Google Scholar 

  131. Greever, C. J. andD. T. Watts, Epinephrine levels in the peripheral blood during irreversible hemorrhagic shock in dogs. Circ. Res.7, 192 (1959).

    PubMed  Google Scholar 

  132. Gremels, H., Zur Physiologie und Pharmakologie der Energetik des Säugetierherzens. Arch. exper. Path. Pharmakol.169, 689 (1933).

    Google Scholar 

  133. Griffith, M. G., J. Q. Griffth jr.,M. B. Hermel, andJ. Gershon-Cohen, Effect of irradiation to adrenal upon circulating adrenal medullary hormone in the rat. Radiology77, 91 (1961).

    PubMed  Google Scholar 

  134. Griffiths, W. J. andS. Collinson, The stimation of noradrenaline in urine and its excretion in normal and hypertensive subjects. J. clin. Pathol.10, 120 (1957).

    PubMed  Google Scholar 

  135. Griswold, R. L., Plasma adrenaline and noradrenaline in electroshock therapy in man and in rats. J. Appl. Physiol.12, 117 (1958).

    PubMed  Google Scholar 

  136. Gurin, S. andA. M. Delluva, The biological synthesis of radioactive adrenaline from phenylalanine. J. biol. Chem.170, 545 (1947).

    Google Scholar 

  137. Hagen, P., Biosynthesis of norepinephrine from 3,4-dihydroxyphenylethylamine. J. Pharmacol. exper. Therap.116, 26 (1956).

    Google Scholar 

  138. Häggendal, J., Fluorimetric determination of 3-0-methylated derivatives of adrenaline and noradrenaline in tissues and body fluids. Acta physiol. Scand.56, 258 (1962).

    PubMed  Google Scholar 

  139. Hamelberg, W., J. H. Sprouse, J. E. Makaffey, andJ. A. Richardson, Catechol amine levels during light and deep anesthesia. Anesthesiol.21, 297 (1960).

    Google Scholar 

  140. Hansson, E. andW. G. Clark, Studies on dopa decarboxylase inhibitors in vivo by use of C14-carboxyl-labeled dopa. Proc. Soc. exp. Biol., N. Y.111, 793 (1962).

    Google Scholar 

  141. Hare, M. L. C., Tyramine oxidase. I. A. new enzyme system in liver. Biochem. J.22, 968 (1928).

    Google Scholar 

  142. Hartman, R. L., R. I. Akawie, andW. G. Clark, Competitive inhibition of 3,4-dihydroxyphenylalanine (DOPA) decarboxylation in vitro. J. biol. Chem.216, 507 (1955).

    PubMed  Google Scholar 

  143. Henning, N. undL. Norpoth, Die Magensekretion während des Schlafes. Dtsch. Arch. klin. Med.172, 558 (1932).

    Google Scholar 

  144. —, Untersuchungen über die sekretorische Funktion des Magens während des nächtlichen Schlafes. Arch. Verdauungskrankh.53, 64 (1932).

    Google Scholar 

  145. Henry, R. J. andC. Sobel, Chemical determination of urinary catecholamines. An aid in the differential diagnosis of essential hypertension and pheochromocytoma. Arch. int. Med.100, 196 (1957).

    Google Scholar 

  146. Hertting, G., J. Axelrod, andL. G. Whitby, Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. exper. Therap.134, 146 (1961).

    Google Scholar 

  147. Hertting, G. andS. M. Hess, The site of binding of injected H3-norepinephrine. Experientia18, 214 (1962).

    PubMed  Google Scholar 

  148. Hertting, G. andE. H. La Brosse, Biliary and urinary excretion of metabolites of 7-H3-epinephrine in the rat. J. biol. Chem.237, 2291 (1962).

    PubMed  Google Scholar 

  149. Hickler, R. B., J. T. Hamlin III andR. E. Wells, Plasma norepinephrine response to tilting in essential hypertension. Circulation20, 422 (1959).

    PubMed  Google Scholar 

  150. Hickler, R. B., R. E. Wells jr.,H. R. Tyler, andJ. T. Hamlin III, Plasma catecholamine and electroencephalographic responses to acute postural change. Evidence of a deficient pressor amine response in postural hypotension. Amer. J. Med.26, 410 (1959).

    PubMed  Google Scholar 

  151. Hill, G. A., J. Ratcliffe, andP. Smith, 3-Ethoxy-4-hydroxybenzoic acid in human urine. Nature, London182, 1161 (1958).

    Google Scholar 

  152. Hillarp, N.-Å., The release of catechol amines from the amine containing granules of the adrenal medulla. Acta physiol. Scand.43, 292 (1958).

    PubMed  Google Scholar 

  153. Hillarp, N.-Å. andB. Hökfelt, Evidence of adrenaline and noradrenaline in separate adrenal medullary cells. Acta physiol. Scand.30, 55 (1953).

    PubMed  Google Scholar 

  154. Hillarp, N.-Å. andB. Nilson, The structure of the adrenaline and noradrenaline containing granules in the adrenal medullary cells with reference to the storage and release of the sympathomimetic amines. Acta physiol. Scand.31, 79 (1954).

    Google Scholar 

  155. Hingerty, D., Thirty-minute screening test for phaeochromocytoma. LancetI, 766 (1957).

    Google Scholar 

  156. Hingerty, D. andM. McBrinn, False-positive tests for pheochromocytoma. LancetII, 558 (1962).

    Google Scholar 

  157. Hirsch, C. W., R. Kuntzman, andE. Costa, Effects of DOPA-5-HTP-decarboxylase inhibition on synthesis of brain amines. Fed. Proc.22, 364 (1962).

    Google Scholar 

  158. Hoffer, A., Adrenochrome in blood plasma. Amer. J. Psychiatr.114, 752 (1958).

    Google Scholar 

  159. Holtz, P., Dopadecarboxylase. Naturwissensch.27, 724 (1939).

    Google Scholar 

  160. Holtz, P., Tyraminbildung durch tierisches Gewebe. Naturwissensch.25, 457 (1937).

    Google Scholar 

  161. —, Chemischer Nachweis der fermentativen Tyraminbildung aus Nierengewebe. Hoppe-Seylers Z. physiol. Chem.251, 226 (1938).

    Google Scholar 

  162. Holtz, P., K. Credner andW. Koepp, Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase. Arch. exper. Path. Pharmakol.200, 356 (1942).

    Google Scholar 

  163. Holtz, P., K. Credner undG. Kroneberg, Über das sympathicomimetische pressorische Prinzip des Harns („Urosympathin”). Arch. exper. Path. Pharmakol.204, 228 (1944/47).

    Google Scholar 

  164. Holtz, P., K. Credner undA. Reinhold, Aminbildung durch Darm. Arch. exper. Path. Pharmakol.193, 688 (1939).

    Google Scholar 

  165. Holtz, P., K. Credner undH. Walter, Über die Spezifität der Aminosäuren-Decarboxylasen. Hoppe-Seylers Z. physiol. Chem.262, 111 (1939).

    Google Scholar 

  166. Holtz, P., G. Kroneberg undH. J. Schümann, Über die sympathikomimetische Wirksamkeit von Herzmuskelextrakten. Arch. exper. Path. Pharmakol.212 551 (1951).

    Google Scholar 

  167. Holtz, P. undH. J. Schümann, Arterenol — ein neues Hormon des Nebennierenmarks. Naturwissensch.35, 159 (1948).

    Google Scholar 

  168. Holtz, P. undE. Westermann, Über die Dopadecarboxylase und Histidindecarboxylase des Nervengewebes. Arch. exper. Path. Pharmakol.227, 538 (1956).

    Google Scholar 

  169. Holzbauer, M. andM. Vogt, The concentration of adrenaline in the peripheral blood during insulin hypoglycaemia. Brit. J. Pharmacol.9 249 (1954).

    PubMed  Google Scholar 

  170. Hökfelt, B., S. Bydgeman undJ. Sekkenes, Die Beteiligung der Nebennieren am Endotoxinschock, inK. D. Bock, Schock, Pathogenese und Therapie. (Berlin-Göttingen-Heidelberg 1962).

  171. Houssay, B. A. andE. A. Molinelli, Adrenal secretion produced by asphyxia. Amer. J. Physiol.76, 538 (1926).

    Google Scholar 

  172. Houssay, B. A. andC. E. Rapela, Adrenal secretion and adrenaline and noradrenaline. Arch. exper. Path. Pharmakol.219, 156 (1953).

    Google Scholar 

  173. Hutchison, G. B., J. A. Evans, andD. C. Davidson, Pitfalls in the diagnosis of pheochromocytoma. Ann. int. Med.48, 300 (1958).

    PubMed  Google Scholar 

  174. Ide, M., The effect of hemorrhage on the noradrenaline and adrenaline contents of the adrenal gland in the cat. Tohoku J. exper. Med.71, 305 (1960).

    Google Scholar 

  175. Iisalo, E., Enzyme action on noradrenaline and adrenaline. Studies on bovine and guinea pig tissues in vitro with special reference to monoamine oxidase. Acta pharmacol. toxicol.19, Suppl.1 (1962).

  176. Imhof, P., F. Hediger undH. Käser, Über Kreislaufregulationsstörungen und Veränderungen der 3-Methoxy-4-hydroxymandelsäure-Ausscheidung im Urin nach traumatischer Querschnittsläsion des Rückenmarks. Helvet. med. Acta29, 183 (1962).

    Google Scholar 

  177. Insley, J. andW. C. Smallwood, Phaeochromocytoma in children. Arch. Dis. Childhood37, 606 (1962).

    Google Scholar 

  178. Iton, C., K. Yoshinaga, T. Sato, N. Ishida, andY. Wada, Presence of N-methylmetadrenaline in human urine and tumour tissue of phaeochromocytoma. Nature, London193, 477 (1962).

    Google Scholar 

  179. Jacobs, S. L., C. Sobel, andR. J. Henry, Excretion of 3-methoxy-4-hydroxymandelic acid and catecholamines in patients with pheochromocytoma. J. clin. Endocr.21, 315 (1961).

    PubMed  Google Scholar 

  180. Kaindl, F. andU. S. von Euler, Liberation of noradrenaline and adrenaline from the suprarenal of the cat during carotid occlusion. Amer. J. Physiol.166, 284 (1951).

    PubMed  Google Scholar 

  181. Kakimoto, Y. andM. D. Armstrong, The phenolic amines of human urine. J. biol. Chem.237, 208 (1962).

    PubMed  Google Scholar 

  182. Kakimoto, Y. andM. D. Armstrong, On the identification of octopamine in mammals. J. biol. Chem.237, 422 (1962).

    PubMed  Google Scholar 

  183. Kärki, N. T., The urinary excretion of noradrenaline and adrenaline in different age groups, its diurnal variations and the effect of muscular work on it. Acta physiol. Scand.39, Suppl.132 (1956).

  184. Kelleher, J. andG. Walters, Chemical tests for phaeochromocytoma. LancetI, 951 (1962).

    Google Scholar 

  185. Keller, E. B., R. A. Boissonas, andV. Du Vigneaud, The origin of the methyl group of epinephrine. J. biol. Chem.183, 627 (1950).

    Google Scholar 

  186. Kirshner, N., Pathway of noradrenaline formation from DOPA. J. biol. Chem.226, 821 (1957).

    PubMed  Google Scholar 

  187. Kirshner, N., Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. biol. Chem.237, 2311 (1962).

    PubMed  Google Scholar 

  188. Kirshner, N., McC. Goodall, andL. Rosen, The effect of iproniazid on the metabolism of dl-epinephrine-2-C14 in the human. J. Pharmacol. exper. Therap.127, 1 (1959).

    Google Scholar 

  189. Kirshner, N., L. Terry, andD. D. Pollard, The metabolism of d,l-adrenaline-2-C14 in the cat. I. Urinary catabolites. Arch. internat. pharmacodyn.131, 421 (1961).

    Google Scholar 

  190. Knauff, H. G., G. Fruhmann undG. Verbeek, Die Ausscheidung von Adrenalin und Noradrenalin bei Asthma bronchiale und bei Lungenemphysem. Klin. Wschr.40, 411 (1962).

    PubMed  Google Scholar 

  191. Knauff, H. G. undG. Verbeek, Fluorimetrische Bestimmung von Adrenalin und Noradrenalin im Harn. Ergebnisse bei Gesunden und bei Patienten mit Hypertonus. Klin. Wschr.40, 18 (1962).

    PubMed  Google Scholar 

  192. Koch, P., P. Lefebvre, R. Lemieux, andC. Laurin, Histamin-induced vanil-mandelic-aciduria in the schizophrenic and the non-schizophrenic psychiatric patient. Amer. J. Psychiatr.119, 464 (1962).

    Google Scholar 

  193. Kopin, I. andJ. Axelrod, Presence of 3-methoxy-4-hydroxyphenylglycol and metanephrine in phaeochromocytoma tissue. Nature, London185, 788 (1960).

    Google Scholar 

  194. Kraupp, O., H. Bernheimer, P. Heistracher, G. Paumgartner undT. Schiefthaler, 1-(4-Hydroxyphenyl)-2-methylaminoaethanol (Sympatol) im Harn eines Falles mit Hochdruckkrisen. Wien. klin. Wschr.73, 712 (1961).

    PubMed  Google Scholar 

  195. Kraupp, O., H. Stormann, H. Bernheimer undH. Obenaus, Vorkommen und diagnostische Bedeutung von Phenolsäuren beim Phaeochromocytom. Klin. Wschr.37, 76 (1959).

    PubMed  Google Scholar 

  196. Kuschke, H. J., Untersuchungen über den Erregungszustand des sympathischen Nervensystems und des Nebennierenmarks bei kardiovaskulären Erkrankungen. Arch. Kreislaufforschg.36, 104 (1961).

    Google Scholar 

  197. Kuschke, H. J. undR. Herzer, Die Brenzkatechin-Ausscheidung bei essentieller Hypertonie unter orthostatischer Belastung. Verh. dtsch. Ges. Kreislaufforschg.28, 232 (1962).

    Google Scholar 

  198. Kuschke, H. J. undK. W. Schneider, Die sympathikoadrenale Reaktion beim Herzinfarkt. Z. Kreislaufforschg.49, 261 (1960).

    Google Scholar 

  199. La Brosse, E. H., J. Axelrod, andS. S. Kety, O-Methylation, the principal route of metabolism of epinephrine in man. Science128, 593 (1958).

    PubMed  Google Scholar 

  200. La Brosse, E. H., J. Axelrod, andA. Sjoerdsma, Urinary excretion of normetanephrine. Fed. Proc.17, 386 (1958).

    Google Scholar 

  201. La Brosse, E. H. andJ. D. Mann, Presence of metanephrine and normetanephrine in normal human urine. Nature, London185, 40 (1960).

    Google Scholar 

  202. La Brosse, E. H. andM. Karon, Metabolism of 2-C14-Dopa in a patient with neuroblastoma. Fed. Proc.21, 360 (1962).

    Google Scholar 

  203. La Brosse, E. H. andM. Karon, Catechol-o-methyltransferase activity in neuroblastoma tumour. Nature, London196, 1222 (1962).

    Google Scholar 

  204. Leeper, L. C., H. Weissbach, andS. Udenfriend, Studies on the metabolism of norepinephrine, epinephrine and their o-methyl analogs by partially purified enzyme preparations. Arch. Biochem.77, 417 (1958).

    PubMed  Google Scholar 

  205. Levi, I., A new stress tolerance test with simultaneous study of physiological and psychological variables. Acta endocrin.37, 38 (1961).

    Google Scholar 

  206. Levin, E. Y. andS. Kaufman, Studies on the enzyme catalyzing the conversion of 3,4-dihydroxyphenylethylamine to norepinephrine. J. biol. Chem.236, 2043 (1961).

    PubMed  Google Scholar 

  207. Lillehei, R. C., J. K. Longerbeam undJ. C. Rosenberg, Das Wesen des irreversiblen Schocks: Seine Beziehungen zu Veränderungen im Bereich des Darmes, inK. D. Bock, Schock, Pathogenese und Therapie (Berlin-Göttingen-Heidelberg 1962).

  208. Litchfield, J. W. andW. S. Peart, Phaeochromocytoma with normal excretion of adrenaline and noradrenaline. LancetII, 1283 (1956).

    Google Scholar 

  209. Loewi, O., Über humorale Übertragbarkeit der Herznervenwirkung. Pflügers Arch. ges. Physiol.189,239 (1921). Über humorale Übertragbarkeit der Herznervenwirkung. II. Mitteilung. Pflügers Arch. ges. Physiol.193, 201 (1922).

    Google Scholar 

  210. —, Quantitative und qualitative Untersuchungen über den Sympathikusstoff. Pflügers Arch. ges. Physiol237, 504 (1936).

    Google Scholar 

  211. Luft, R. andU. S. von Euler, Effect of insulin hypoglycemia on urinary excretion of adrenaline and noradrenaline in man after hypophysectomy. J. clin. Endocr.16, 1017 (1956).

    PubMed  Google Scholar 

  212. Mac Laglan, N. F. andJ. H. Wilkinson, Methylation of a phenolic group in the human body. Nature, London168, 251 (1951).

    Google Scholar 

  213. Manger, W. M., J. L. Bollman, F. T. Maher, andJ. Berkson, Plasma concentration of epinephrine and norepinephrine in hemorrhagic and anaphylactic shock. Amer. J. Physiol.190, 310 (1957).

    PubMed  Google Scholar 

  214. Markason, C. R., J. F. Keighley, H. Smulyan, andR. H. Eich, Effect of reserpine on circulatory catecholamines and on hemodynamic responses to infused norepinephrine. 34th Sci. Sess., Amer. Heart Ass. 1961. Circulation24, 988 (1961).

    Google Scholar 

  215. Mason, J. W., G. Mangan, J. V. Brady, D. Conrad, andD. McK. Rioch, Concurrent plasma epinephrine, norepinephrine and 17-hydroxycorticosteroid levels during conditioned emotional disturbances in monkeys. Psychosomat. Med.23, 344 (1961).

    Google Scholar 

  216. Masuoka, D. T., H. F. Schott, R. I. Akawie, andC. G. Clark, Conversion of C14-arterenol to epinephrine in vivo. Proc. Soc. exp. Biol., N. Y.93, 5 (1956).

    Google Scholar 

  217. McDonald, R. K. andV. K. Weise, The effect of certain psychotropic drugs on the urinary excretion of 3-methoxy-4-hydroxy-mandelio acid in man. J. Pharmacol. exper. Therap.136, 26 (1962).

    Google Scholar 

  218. McGeer, P.L., J. E. Boulding, W. C. Gibson, andR. G. Foukes, Drug induced extrapyramidal reactions. Treatment with diphenhydramin hydrochloride and dihydroxyphenylalanine. J. Amer. Med. Ass.177, 665 (1961).

    Google Scholar 

  219. Miyake, H., H. Yoshida, andR. Imaizumi, Determination methods for urinary 3-methoxy-4-hydroxymandelic acid and 3,4-dihydroxymandelic acid. Jap. J. Pharmacol.12, 79 (1962).

    Google Scholar 

  220. Montanari, R., E. Costa, M. A. Beaven, andB. B. Brodie, Turnover rates of norepinephrine in hearts of intact mice, rats and guinea pigs using tritiated norepinephrine. Life Sciences4, 232 (1963).

    Google Scholar 

  221. Morris, M. E. andR. A. Millar, Blood pH/plasma catecholamine relationships: respiratory acidosis. Brit. J. Anaesth.34, 672 (1962).

    Google Scholar 

  222. Murphy, G. F. andT. L. Sourkes, The action of antidecarboxylases on the conversion of 3,4-dihydroxyphenylalanine to dopamine in vivo. Arch. Biochem.93, 338 (1961).

    PubMed  Google Scholar 

  223. Nakano, J., H. Zekert, C. W. Griege, Kuang-Mei Wang, H. S. Schaefer, andR. Wégria, Effect of ventricular tachycardia and atriovenous fistula on catecholamine blood level. Amer. J. Physiol.200, 413 (1961).

    PubMed  Google Scholar 

  224. Naurok, D. S., G. Gwinap, andG. J. Hamwi, Phentolamine-resistant pheochromocytoma treated with sodium nitroprusside. J. Amer. Med. Ass.183, 841 (1963).

    Google Scholar 

  225. Nolan, C. andM. D. Armstrong, Occurence of ethylvanillic acid in human urine and its metabolism. Proc. Soc. exper. Biol., N. Y.103, 716 (1960).

    Google Scholar 

  226. Oliver, G. andE. A. Schaefer, The physiological effects of extracts of the suprarenal capsules. J. Physiol., London18, 230 (1895).

    Google Scholar 

  227. Pekkarinen, A., Adrenaline and noradrenaline in blood and urine. Pharmacol. Rev.6, 35 (1954).

    PubMed  Google Scholar 

  228. Pekkarinen, A., O. Castrén, E. Iisalo,

  229. Pekkarinen, A., E. Iisalo, A. Kasanen, A. Laikinen, andB. Thomasson, The adrenosympathetic and adrenocortical function in cardiac insufficiency. Amer. J. Cardiol.5, 604 (1960).

    PubMed  Google Scholar 

  230. Pincoffs, M. G., Case of paroxysmal hypertension associated with suprarenal tumor. Tr. A. Amer. Phys.44, 295 (1929).

    Google Scholar 

  231. Pletscher, A., K. F. Gey u.P. Zeller, Monoaminoxydasehemmer. Chemie, Biochemie, Pharmakologie, Klinik. Fortschr. Arzneimittelforschg. (ed.:E. Jukker)2, 417 (1960).

    Google Scholar 

  232. Pisano, J. J., A simple analysis for normetanephrine and metanephrine in urine. Clin. chim. Acta5, 406 (1960).

    PubMed  Google Scholar 

  233. Pisano, J. J., J. R. Crout, andD. Abraham, Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin. chim. Acta7, 285 (1962).

    PubMed  Google Scholar 

  234. Pisano, J. J., J. A. Oates jr.,A. Karmen, A. Sjoerdsma, andS. Udenfriend, Identification of phydroxy-alpha-(methylaminomethyl)-benzyl alcohol (synephrine) in human urine. J. biol. Chem.236, 898 (1961).

    PubMed  Google Scholar 

  235. Pitkänen, E., Studies on the determination and excretion of adrenaline and noradrenaline in the urine. Acta physiol. Scand.38, Suppl.129 (1956).

  236. Raab, W., Neurohumoral bedingte Herzkrankheiten. Arch. Kreislaufforschg.15, 39 (1949).

    Google Scholar 

  237. Raab, W. undW. Gigee, Die Katecholamine des Herzens. Arch. exper. Path. Pharmakol.219, 248 (1953).

    Google Scholar 

  238. Raab, W. andW. Gigee, Norepinephrine and epinephrine content of normal and diseased human hearts. Circulation11, 593 (1955).

    PubMed  Google Scholar 

  239. Raab, W. andW. Gigee, Uptake and breakdown of catecholamines in vascular tissue. Angiol.9, 283 (1958).

    Google Scholar 

  240. Raab, W., E. Lepeschkin, Y. K. Starcheska, andW. Gigee, Cardiotoxic effects of hypercatecholemia in renal insufficiency. Circulation14, 614 (1956).

    PubMed  Google Scholar 

  241. Richardson, J. A., E. F. Woods andE. E. Bagwell, Circulating epinephrine and norepinephrine in coronary occlusion. Amer. J. Cardiol.5, 613 (1960).

    Google Scholar 

  242. Richter, D., The inactivation of adrenaline in vivo in man. J. Physiol., London98, 361 (1940).

    Google Scholar 

  243. Ritzel, G. undW. A. Hunzinger, Über die Bestimmung von Katecholaminen im Urin. Normalwerte in Abhängigkeit vom Lebensalter und Befunde bei Hypertonie. Klin. Wschr.41, 419 (1963).

    PubMed  Google Scholar 

  244. Robinson, R. andA. F. Munro, Adrenal activity in subjects with complete transverse lesions of the spinal cord. Nature, London182, 805 (1958).

    Google Scholar 

  245. Robinson, R. andP. Smith, Urinary phenols in stress. Nature, London186, 240 (1960).

    Google Scholar 

  246. Robinson, R. andP. Smith, Adrenaline-secreting phaeochromocytomata. LancetII, 250 (1962).

    Google Scholar 

  247. Robinson, R. andP. Smith, Urinary amines in phaeochromocytoma. Clin. chim. acta7, 29 (1962).

    PubMed  Google Scholar 

  248. Robinson, R. L. andK. E. Jochim, Histamine and anaphylaxis on adrenal medullary secretion in dogs. Amer. J. Physiol.199, 429 (1960).

    PubMed  Google Scholar 

  249. Robinson, R. L. andD. T. Watts, Inhibition of adrenal secretion of epinephrine during infusions of catecholamines. Amer. J. Physiol.203, 713 (1962).

    PubMed  Google Scholar 

  250. Rose, K. G. undH. Buttenberg, Beitrag zu den Tumoren des Glomus caroticum und des Glomus jugulare-tympanicum: Klinik, Diagnose, Therapie. Z. Laryngol., Rhinol., Otol.42, 240 (1963).

    Google Scholar 

  251. Rosen, L. andMcC. Goodall, Identification of vanillic acid as a catabolite of noradrenaline metabolism in the human. Proc. Soc. exper. Biol., N. Y.110, 767 (1962).

    Google Scholar 

  252. Rosen, L. andMcC. Goodall, Effect of iproniazid on metabolism of noradrenaline in man. Amer. J. Physiol.202, 883 (1962).

    PubMed  Google Scholar 

  253. Rosenfeld, G., L. C. Leeper, andS. Udenfriend, Biosynthesis of norepinephrine and epinephrine by the isolated, perfused calf adrenal. Arch. Biochem.74, 252 (1958).

    PubMed  Google Scholar 

  254. Roth, G. M. andW. F. Kvale, Tentative test for pheochromocytoma. Amer. J. Med. Sci.210, 653 (1945).

    Google Scholar 

  255. Roston, S., The effect of coenzyme A upon the oxidation of epinephrine and norepinephrine. J. biol. Chem.235, 3315 (1960).

    PubMed  Google Scholar 

  256. Ruthven, C. R. J., Determination of metabolites of catecholamines by other techniques, in Symposium on the clinical chemistry of monoamines, Manchester 1962. Elsevier Publ. Co., Amsterdam 1963.

    Google Scholar 

  257. Ruthven, C. R. J. andM. Sandler, The estimation of homovanillic acid in urine. Biochem. J.83, 30 P (1962).

    Google Scholar 

  258. Sack, H., Das Phaeochromocytom (Stuttgart 1951).

  259. Sack, H. undF. Koll, Schwierigkeiten der Phaeochromocytomdiagnostik. Grenzen und Möglichkeiten des Regitintests. Dtsch. med. Wschr.79, 390 (1954).

    PubMed  Google Scholar 

  260. Sack, H. undJ. F. Koll, Der heilbare Bluthochdruck beim Nebennierenmarktumor. Forum cardiol.4, 1 (1962).

    Google Scholar 

  261. Sandler, M. andC. R. J. Ruthven, Quantitative colorimetric method for estimation of 3-methoxy-4-hydroxymandelic acid in urine; value in diagnosis of phaeochromocytoma. LancetII, 114 (1959).

    Google Scholar 

  262. Sandler, M. andC. R. J. Ruthven, The estimation of 3-methoxy-4-hydroxymandelic acid in urine. LancetII, 1034 (1959).

    Google Scholar 

  263. Sandler, M. andC. R. J. Ruthven, The estimation of 4-hydroxy-3-methoxy-mandelic acid in urine. Biochem. J.80, 78 (1961).

    PubMed  Google Scholar 

  264. Sann, E., Der Einfluß des Nicotins in der Grenzdosis auf die Adrenalinausschüttung der Nebennieren. Inaugural-Diss. (Heidelberg 1945).

  265. Sato, T., K. Yoshinaga, N. Ishida, C. Itoh, andY. Wada, Advanced screening test for pheochromocytoma and argentaffinoma. Tohoku J. exper. Med.77, 78 (1962).

    Google Scholar 

  266. Sato, T., K. Yoshinaga, Y. Wada, N. Ishida, andC. Itoh, Urinary excretion of catecholamines and their metabolites in normotensive and hypertensive subjects. Tohoku J. exper. Med.75, 151 (1961).

    Google Scholar 

  267. De Schaepdryver, A. F. andN. Kirshner, Metabolism of adrenaline after blockage of monoamine oxidase and catechol-o-methyl transferase. Science133, 586 (1961).

    PubMed  Google Scholar 

  268. De Schaepdryver, A. F. andN. Kirshner, The metabolism of d,1-adrenaline-2-C14 in the cat. II. Tissue metabolism. Arch. internat. pharmacodyn.131, 433 (1961).

    Google Scholar 

  269. De Schaepdryver, A. F. andJ. G. Leroy, Urinary volume and catecholamine excretion in man. Acta cardiol. (Bruxelles)16, 631 (1961).

    Google Scholar 

  270. Schaub, F., F. Nager, H. Schaer, W. Ziegler undP. Lichtlen, Alpha-methyl-dopa. Therapeutische Erfahrungen bei Hypertonie und biochemische Untersuchungen zu seiner Wirkungsweise. Schweiz. med. Wschr.92, 620 (1962).

    PubMed  Google Scholar 

  271. Schayer, R. W., Studies on the metabolism of β-C14-adrenaline. J. biol. Chem.189, 301 (1951).

    PubMed  Google Scholar 

  272. Schayer, R. W., R. L. Smiley, K. J. Davis, andY. Kobayashi, Role of monoamine oxidase in noradrenaline metabolism. Amer. J. Physiol.182, 285 (1955).

    PubMed  Google Scholar 

  273. Schayer, R. W., R. L. Smiley, andJ. Kennedy, Metabolism of epinephrine containing isotopic carbon III. J. biol. Chem.202, 425 (1953).

    PubMed  Google Scholar 

  274. Scheline, R. R., R. T. Williams, andJ. G. Wit, Biological dehydroxylation. Nature, London188, 849 (1960).

    Google Scholar 

  275. Schmid, E., K. Bachmann, Chr. Meythaler, K. Meythaler, H. Schön undN. Henning, Klinische und biochemische Untersuchungen beim Karzinoid. Münchner. med. Wschr.105, 893 (1963).

    Google Scholar 

  276. Schmid, E. undN. Henning, Über den Nachweis der 3-Methoxy-4-hydroxymandelsäure im Harn. Klin. Wschr.41, 566 (1963).

    Google Scholar 

  277. Schmid, E. undH. G. Knauff, Untersuchungen am ermüdeten und gelähmten oberen Cervicalganglion. Die Wirkung von Nicotin, Anabasin, Cytisin und Lobelin. Arch. exper. Path. Pharmakol.222, 330 (1954).

    Google Scholar 

  278. Schmid, E., L. Zicha, J. Krautheim undJ. Blumberg, Dünnschichtchromatographische Trennung von Substanzen des Katecholamin- und Serotonin-Stoffwechsels. Med. exper.7, 8 (1962).

    Google Scholar 

  279. Schmiterlöw, C. G., Formation in vivo of noradrenaline from 3,4-dihydroxyphenylserine (noradrenaline carboxylic acid). Brit. J. Pharmacol.6, 127 (1951).

    PubMed  Google Scholar 

  280. Schuler, W. undA. Wiedemann, Über die Adrenalinsynthese im Reagenzglase unter physiologischen Bedungungen. Hoppe-Seylers Z. physiol. Chem.233, 235 (1935).

    Google Scholar 

  281. Schümann, H. J., Hormon- und ATP-Gehalt des menschlichen Nebennierenmarks und des Phaeochromocytomgewebes. Klin. Wschr.38, 11 (1960).

    PubMed  Google Scholar 

  282. Schümann, H. J., Die biochemische Diagnose des Phaeochromocytoms. Dtsch. med. Wschr.86, 2016 (1961).

    Google Scholar 

  283. Sharman, D. F., A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue. Brit. J. Pharmacol.20, 204 (1963).

    PubMed  Google Scholar 

  284. Shaw, K. N. F., A. McMillan, andM. Armstrong, The metabolism of 3,4-dihydroxyphenylalanine. J. biol. Chem.226, 255 (1957).

    PubMed  Google Scholar 

  285. Shaw, K. N. F. andJ. Trevarthen, Exogenous sources of urinary phenol and indole acids. Nature, London182, 797 (1958).

    Google Scholar 

  286. Shore, P. A., Release of serotonin and catecholamines by drugs. Pharmacol. Rev.14, 531 (1962).

    PubMed  Google Scholar 

  287. Shore, P. A. andJ. S. Olin, Identification and chemical assay of norepinephrine in brain and other tissues. J. Pharmacol. exper. Therap.122, 295 (1958).

    Google Scholar 

  288. Sjoerdsma, A., L. C. Leeper, L. L. Terry, andS. Udenfriend, Studies on the biogenesis and metabolism of norepinephrine in patients with pheochromo-cytoma. J. clin. Invest.38, 21 (1959).

    PubMed  Google Scholar 

  289. Smith, E. R. B. andH. Weil-Malherbe, Metanephrine and normetanephrine in human urine: Method and results. J. Lab. clin. Med.60, 212 (1962).

    PubMed  Google Scholar 

  290. Smith, P., Significance of urinary vanillic acids. Nature, London182, 1741 (1958).

    Google Scholar 

  291. Smith, P. andA. M. H. Bennett, Vanillic acid excretion during stress. Nature, London181, 709 (1958).

    Google Scholar 

  292. Smithwick, R. H., W. E. R. Greer, C. W. Robertson, andR. W. Wilkinson, Pheochromocytoma. New Engl. J. Med.242, 252 (1950).

    PubMed  Google Scholar 

  293. Spector, S., K. Melmon, andA. Sjoerdsma, Evidence for rapid turnover of norepinephrine in rat heart and brain. Proc. Soc. exper. Biol. N. Y.111, 79 (1962).

    Google Scholar 

  294. Sourkes, T. L., Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanine. Arch. Biochem.51, 444 (1954).

    PubMed  Google Scholar 

  295. Sourkes, T. L., G. F. Murphy, andA. Rabinovitch, Conversion of d, 1-m-tyrosine to dopamine in the rat. Nature, London189, 577 (1961).

    Google Scholar 

  296. Stahl, E., Dunnschichtchromatographie in der Pharmazie (zusammenfassende Darstellung). Pharm. Rundsch.2, 1 (1959).

    Google Scholar 

  297. Stahl, E., Dünnschichtchromatographie (Berlin-Göttingen-Heidelberg 1962).

  298. Steiness, I., Hypotension due to an adrenaline-secreting phaeochromocytoma. LancetII, 1149 (1961).

    Google Scholar 

  299. Straus, R. andM. Wurm, Catecholamines and the diagnosis of pheochromocytoma. A review and evaluation. Am. J. clin. Pathol.34, 403 (1960).

    Google Scholar 

  300. v. Studnitz, W., Excretion of 3-methoxy-4-hydroxymandelic acid in patients with serotonin producing tumors. Scand. J. Clin. & Lab. Invest.11, 309 (1959).

    Google Scholar 

  301. v. Studnitz, W., Methodische und klinische Untersuchungen über die Ausscheidung der 3-Methoxy-4-hydroxymandelsäure im Urin. Scand. J. Clin. & Lab. Invest.12, Suppl.48 (1960).

  302. v. Studnitz, W. andA. Hanson, Determination of 3-methoxy-4-hydroxymandelic acid in urine by high-voltage paper electrophoresis. Scand. J. Clin. & Lab. Invest.11, 101 (1959).

    Google Scholar 

  303. Sturm, A. jr., Erhöhtes Vorkommen, Bedeutung und Bestimmung der Vanillinsäure im Harn beim Phaeochromoblastom. Dtsch. med. Wschr.88, 1000 (1963).

    PubMed  Google Scholar 

  304. Sulman, F. G., N. Hirsch, andJ. Pfeifer, Effect of hot dry desert winds (sharav, hamsin) on the metabolism of hormones. Harefuah63, 1 (1962).

    PubMed  Google Scholar 

  305. Sunderman, F. W. jr.,P. D. Cleveland, N. C. Law, andF. W. Sunderman, A method for the determination of 3-methoxy-4-hydroxymandelic acid (“vanilmandelic acid”) for the diagnosis of pheochromocytoma. Amer. J. clin. Pathol.34, 293 (1960).

    Google Scholar 

  306. Sundin, T., The effect of body posture on the urinary excretion of adrenaline and noradrenaline. Acta med. scand.161, suppl.336 (1958).

  307. —, Symposium on Catecholamines, Bethesda 1958. The Williams & Wilkins Co., Baltimore 1959 [Pharmacol. Rev.11, 241 (1959)].

    Google Scholar 

  308. Szara, S., J. Axelrod, andS. Perlin, Is adrenochrome present in the blood? Amer. J. Psychiatr.115, 162 (1958).

    Google Scholar 

  309. Trendelenburg, P., Über die Adrenalinkonzentration im Säugetierblut. Arch. exper. Path. Pharmakol.79, 154 (1916).

    Google Scholar 

  310. Udenfriend, S., J. R. Cooper, C. T. Clark, andJ. E. Baer, Rate of turnover of epinephrine in the adrenal medulla. Science117, 663 (1953).

    PubMed  Google Scholar 

  311. Udenfriend, S. andJ. B. Wyngaarden, Precursors of adrenal epinephrine and norepinephrine in vivo. Biochim. biophys. acta20, 48 (1956).

    PubMed  Google Scholar 

  312. Unghváry, L., I. Csomai, M. Hoványi undF. Farkas, Wirkung der Konzentration der Gesamtkatecholaminstoffe des Vollblutes und deren Veränderung unter der Wirkung des Rauchens. Cardiologia41, 316 (1962).

    PubMed  Google Scholar 

  313. Vendsalu, A., Studies on adrenaline and noradrenaline in human plasma. Acta physiol. Scand.40, Suppl.173 (1960).

  314. Voorhess, M. L. andL. I. Gardner, Urinary excretion of norepinephrine, epinephrine and 3-methoxy-4-hydroxymandelic acid by children with neuroblastoma. J. clin. Endocr.21, 321 (1961).

    PubMed  Google Scholar 

  315. Voorhess, M. L. andL. I. Gardner, Neuroblastoma and catecholamine excretion. LancetI, 1288 (1961).

    Google Scholar 

  316. Vulpian, M., Note sur quelques réactions propres à la substance des capsules surrénales. C. R. Acad. Sci., Paris43, 663 (1856).

    Google Scholar 

  317. Waalkes, T. P., A. Sjoerdsma, H. Weissbach, andS. Udenfriend, Serotonin, norepinephrine and related compounds in bananas. Science127, 648 (1958).

    Google Scholar 

  318. Waddell, W. R., G. D. Zuidema, andG. M. Smith, Catechol amine excretion by duodenal ulcer patients. J. clin. Invest.39, 834 (1960).

    Google Scholar 

  319. Waldi, D., Quantitative Bestimmung von Adrenalinlösungen mit Hilfe der dünnschichtchromatographischen Vergleichsmethode. Arch. Pharmazie225, 125 (1962).

    Google Scholar 

  320. Waldi, D., Persönliche Mitteilung.

  321. Walker, W. F., W. C. Shoemaker, A. J. Kallstad, andF. D. Moore, Influence of blood volume restoration and tissue trauma on corticosteroid secretion in dogs. Amer. J. Physiol.197, 781 (1959).

    PubMed  Google Scholar 

  322. Walker, W. F., M. S. Zileli, F. W. Reutter, W. C. Shoemaker, D. Friend, andF. D. Moore, Adrenal medullary secretion in hemorrhagic shock. Amer. J. Physiol.197, 773 (1959).

    Google Scholar 

  323. Walker, W. F., M. S. Zileli, F. W. Reutter, W. C. Shoemaker, andF. D. Moore, Factors influencing the “resting” secretion of the adrenal medulla. Amer. J. Physiol.197, 765 (1959).

    Google Scholar 

  324. Walton, R. P., J. A. Richardson, R. P. Walton, jr., andW. L. Thompson, Sympathetic influences during hemorrhagic hypotension. Amer. J. Physiol.197, 223 (1959).

    PubMed  Google Scholar 

  325. Watts, D. T., Arterial blood epinephrine levels during hemorrhagic hypotension in dogs. Amer. J. Physiol.184, 271 (1956).

    PubMed  Google Scholar 

  326. Watts, D. T. andA. D. Bragg, Effect of smoking on the urinary output of epinephrine and norepinephrine in man. J. Appl. Physiol.9, 275 (1956).

    PubMed  Google Scholar 

  327. Weil-Malherbe, H. andA. D. Bone, The flourimetric estimation of adrenaline and noradrenaline in plasma. Biochem. J.67, 65 (1957).

    PubMed  Google Scholar 

  328. Weil-Malherbe, H. andA. D. Bone, The estimation of catecholamines in urine by a chemical method. J. clin. Pathol.10, 138 (1957).

    PubMed  Google Scholar 

  329. Weise, V. K., R. K. McDonald, andE. H. La Brosse, Determination of urinary 3-methoxy-4-hydroxymandelic acid in man. Clin. chim. acta6, 79 (1961).

    PubMed  Google Scholar 

  330. Werle, E. undD. Aures, Über die Reinigung und Spezifität der DOPA-Decarboxylase. Hoppe-Seylers Z. physiol. Chem.316, 45 (1957).

    Google Scholar 

  331. Werle, E. undG. Mennicken, Über die Bildung von Tryptamin aus Tryptophan und von Tyramin aus Tyrosin durch tierisches Gewebe. Biochem. Z.291, 325 (1937).

    Google Scholar 

  332. Werle, E. undJ. Sell, Über die fermentative Dekarboxylierung von Mono- und Dioxyphenylserin. Biochem. Z.326, 110 (1954).

    PubMed  Google Scholar 

  333. Westermann, E., H. Balzer undJ. Knell, Hemmung der Serotoninbildung durch Alpha-methyl-Dopa. Arch. exper. Path. Pharmakol.234, 194 (1958).

    Google Scholar 

  334. Whitby, L. G., J. Axelrod, andH. Weil-Malherbe, The fate of H3-norepinephrine in animals. J. Pharmacol. exper. Therap.132, 193 (1961).

    Google Scholar 

  335. Williams, C. M., The effect of reserpine on dopamine metabolism in humans. J. Neurochem.9, 335 (1962).

    PubMed  Google Scholar 

  336. Williams, C. M., A. A. Babuscio, andR. Watson, In vivo alteration of the pathways of dopamine metabolism. Amer. J. Physiol.199, 722 (1960).

    PubMed  Google Scholar 

  337. Williams, C. M. andM. Greer, Diagnosis of neuroblastoma by quantitative gas chromatographic analysis of urinary homovanillic and vanilmandelic acid. Clin. chim. acta7, 880 (1962).

    PubMed  Google Scholar 

  338. Williams, C. M. andM. Greer, Diagnosis of neuroblastoma. J. Amer. Med. Ass.183, 836 (1963).

    Google Scholar 

  339. Willey, G. L., Effect of antisympathomimetic drugs on the plasma concentrations of catechol amines. Brit. J. Pharmacol.19, 365 (1962).

    PubMed  Google Scholar 

  340. Woiwod, A. J. andR. Knight, The determination of 3-methoxy-4-hydroxymandelic acid in urine. J. clin. Pathol.14, 502 (1961).

    PubMed  Google Scholar 

  341. Wolfe, D. E., L. T. Potter, K. C. Richardson, andJ. Axelrod, Localizing tritiated norepinephrine in sympathetic axons by electron microscopic autoradiography. Science138, 440 (1962).

    PubMed  Google Scholar 

  342. Wollheim, E. undJ. Moeller, Phaeochromocytom, in Hypertonie und Hypotonie, Hdbch. inn. Med.9, Teil V, S. 646 (Berlin-Göttingen-Heidelberg 1960).

    Google Scholar 

  343. Woods, E. F. andJ. A. Richardson, Further studies correlating catechol amine levels with cardiovascular functions. J. Pharmacol. exper. Therap.119, 195 (1957).

    Google Scholar 

  344. Woods, E. F., J. A. Richardson, A. K. Richardson, andR. F. Bozeman jr., Plasma concentrations of epinephrine and arterenol following the actions of various agents on the adrenal. J. Pharmacol. exper. Therap.116, 351 (1956).

    Google Scholar 

  345. Yoshinaga, K., C. Itoh, N. Ishida, T. Sato, andY. Wada, Quantitative determination of metadrenaline and normetadrenaline in normal human urine. Nature, London191, 599 (1961).

    Google Scholar 

  346. Yoshinaga, K., T. Sato andN. Ishida, Studies on the role of noradrenaline in the pathogenesis of hypertension. Tohoku J. exper. Med.72, 301 (1960).

    Google Scholar 

  347. Zeisel, H., Abbauprodukte der Catechinamine im Harn des Kindes. Z. Kinderhk.86, 89 (1961).

    Google Scholar 

  348. Zeisel, H. undH. J. Kuschke, Die Catechinamine Adrenalin und Noradrenalin im Harn des Kindes. Klin. Wschr.37, 1168 (1959).

    PubMed  Google Scholar 

  349. Ziegler, W., Die Bedeutung der Vanillin-Mandelsäure (VMS) für die Diagnostik des Phaeochromocytoms und für die Untersuchung des Katecholaminstoffwechsels. Helv. med. acta27, 647 (1960).

    PubMed  Google Scholar 

  350. Zileli, M. S., J. T. Hamlin III, F. W. Reutter, andD. G. Friend, Evaluation of catechol amine levels in renal insufficiency. J. clin. Invest.37, 409 (1958).

    PubMed  Google Scholar 

  351. Zuidema, G. D., A. J. Ziverman, S. I. Cohen, andMcC. Goodall, Catechol amine and psychological correlates of vascular responses. New Engl. J. Med.256, 976 (1957).

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. E. Schmid

    Present address: Medizinischen Klinik der Universität Erlangen-Nürnberg, Krankenhausstr. 12, 852, Erlangen

Authors and Affiliations

    Authors
    1. E. Schmid
      View author publications

      You can also search for this author in PubMed Google Scholar

    Additional information

    Mit 10 Abbildungen und 3 Tabellen

    Mit Unterstützung der Deutschen Forschungsgemeinschaft.

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Schmid, E. Untersuchungen über Physiologie und Pathophysiologie des sympathikoadrenalen Systems durch Bestimmung der Vanillin-Mandelsäure-Ausscheidung im Harn mit dünnschichtehromatographischer Technik. Archiv für Kreislaufforschung 49, 83–116 (1966). https://doi.org/10.1007/BF02134607

    Download citation

    • Received:

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF02134607

    Search

    Navigation